Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohort
Loreta A. Kondili(Istituto Superiore di Sanità), Matteo Ruggeri(Horta (Italy)), Giovanni Battista Gaeta, Massimo Puoti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Federica Romano(Università Cattolica del Sacro Cuore), Marco Massari(Azienda Sanitaria Unità Locale di Reggio Emilia), Alfredo Di Leo(University Gastroenterology), Guglielmo Borgia(University of Naples Federico II), A. Albertí(University of Padua), Luchino Chessa(University of Cagliari), Francesco Paolo Russo(University of Padua), Pierluigi Blanc, Anna Linda Zignego(University of Florence), Antonio Gasbarrini(Università Cattolica del Sacro Cuore), Giuseppe Foti(University of Milano-Bicocca), Salvatore Madonia(Ospedale Vincenzo Cervello), Marcello Persico(University of Salerno), Gabriella Verucchi(University of Bologna), Francesca Romana Rolli(Università Cattolica del Sacro Cuore), M. Vinci(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Gloria Taliani(Sapienza University of Rome), Liliana Chemello(University of Padua), Erica Villa(University of Modena and Reggio Emilia), Giovanni Raimondo(University of Messina), Alessia Ciancio(Department of Medical Sciences), Carlo Ferrari(University of Parma), Gerardo Nardone(Federico II University Hospital), Pietro Andreoné, Americo Cicchetti(Università Cattolica del Sacro Cuore), Stefano Rosato(University of Helsinki), Stefano Vella, Maurizia Rossana Brunetto(University of Pisa), Giuseppe Montalto(University of Palermo), Massimo Zuin(AOL (United States)), Teresa Santantonio(Ospedali Riuniti di Foggia), Elke Erne(University of Padua), Donatella Ieluzzi(University of Verona), Maria Grazia Rumi(University of Milan), Antonio Craxı̀(University of Palermo), Maria Giovanna Quaranta(Istituto Superiore di Sanità), Carmine Coppola
Cited by 29
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Treatment for Adult HIV Infection
|JAMA|2006|1k
Antiretroviral Therapy in Adults
|JAMA|2000|1k
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k